Wai L Lau

Wai L Lau, M.D.

Clinical Assistant Professor

Department: MD-NEPHROLOGY
Business Phone: (352) 273-8821

About Wai L Lau

I am an assistant professor in the University of Florida Division of Nephrology, Hypertension and Renal Transplantation, within the areas of internal medicine and nephrology, and I am board certified in both. I specialize in the treatment and research of glomerular diseases, and I am committed to improving patient care by providing access to novel treatment options via clinical studies for glomerular diseases.

I completed medical school in 1995 at State University of New York Health Science Center and completed my internal residency at the University of Massachusetts Medical Center, where I subsequently completed a nephrology fellowship. I also completed a glomerular fellowship at Columbia University Medical Center.

I am the principle investigator of several studies here at the UF for IgA glomerulonephritis and FSGS. Patient participation in these clinical studies gives greater access to treatments that are otherwise limited and suboptimal. It is my joy being able to provide patients, often younger, get treatment to improve their lives.

When not practicing at UF Health Nephrology – Shands Hospital, I enjoy keeping up with my personal interests: hiking, cooking and photography.

Board Certifications

  • Internal Medicine
    American Board of Internal Medicine
  • Nephrology
    American Board of Internal Medicine

Clinical Profile

Specialties
  • Nephrology
Areas of Interest
  • Glomerulonephritis
  • Lupus nephritis

Research Profile

Areas of Interest
  • Glomerulonephritis
  • lupus nephritis

Grants

Feb 2024 – Mar 2024
VX19-NEN-801: A Study of the Prevalence of Apolipoprotein L1 (APOL1) Alleles Among Individuals With Proteinuric Kidney Disease Who Are of Recent African Ancestry or Geographic Origin
Role: Principal Investigator
Funding: VERTEX PHARMACEUTICALS
Nov 2023 ACTIVE
A Phase 2b/3, Multi-part, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Atacicept in Subjects with IgA Nephropathy (IgAN)
Role: Principal Investigator
Funding: MEDPACE via VERA THERAPEUTICS
Sep 2022 ACTIVE
A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Subjects Aged 18 Years and Older With APOL1-mediated Proteinuric Kidney Disease
Role: Principal Investigator
Funding: VERTEX PHARMACEUTICALS
Jan 2022 ACTIVE
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients with IgA Nephropathy at Risk of Progressive Loss of Renal Function (The ALIGN Study)
Role: Principal Investigator
Funding: CHINOOK THERAPEUTICS
Mar 2021 ACTIVE
An Open Label Extension (OLE) Study to Evaluate The Efficacy and Safety of Nefecon Treatment in Patients with IGA Nephropathy Who Have Completed Study NEF-301
Role: Principal Investigator
Funding: MEDPACE via CALLIDITAS THERAPEUTICS
Oct 2020 ACTIVE
A multi-center, randomized, double-blind, placebo-controlled, parallel group, phase III study to evaluate the efficacy and safety of LNP023 on proteinuria and renal function decline in primary IgA nephropathy patients
Role: Principal Investigator
Funding: NOVARTIS PHARMACEUTICALS CORP
Feb 2020 ACTIVE
A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PARALLEL, ACTIVE-CONTROL STUDY OF THE EFFECTS OF SPARSENTAN, A DUAL ENDOTHELIN RECEPTOR AND ANGIOTENSIN RECEPTOR BLOCKER, ON RENAL OUTCOMES IN PATIENTS WITH PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
Role: Principal Investigator
Funding: IQVIA Holdings via TRAVERE THERAPEUTICS
Oct 2019 – Jun 2023
A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF NEFECON IN PATIENTS WITH PRIMARY IGA NEPHROPATHY AT RISK OF PROGRESSING TO END-STAGE RENAL DISEASE (NefIgArd)
Role: Principal Investigator
Funding: MEDPACE via CALLIDITAS THERAPEUTICS

Education

Glomerular Fellowship
2018 · Columbia University Medicial Center
Nephrology Fellowship
2010 · University of Massachusetts Medical Center
Internal Medicine Residency
1998 · University of Massachusetts Medical Center
Medical Degree
1995 · State University of New York Health Science Center

Contact Details

Phones:
Business:
(352) 273-8821
Addresses:
Business Mailing:
PO Box 100224
GAINESVILLE FL 32610
Business Street:
PO Box 100224
GAINESVILLE FL 32610